Jan Groen founded DXOrange BV. Currently, he is Chief Executive Officer & Director at Novigenix SA.
He is also on the board of ANGLE Plc, Saving Patients' Lives Medical BV and Destina Genomics Ltd.
He previously was CEO, Executive Director & Head-Investor Relations at MDxHealth SA, Chief Operating Officer at Agendia NV and President of Agendia, Inc. (a subsidiary of Agendia NV), Principal at Akzo Nobel NV, Principal at ViroClinics Biosciences BV, Vice President-Research & Development of Focus Diagnostics, Inc. and Principal at Erasmus MC.
Jan Groen received a doctorate from Erasmus University Rotterdam.